Bharat Parenterals cash flow

Latest FY23
Cash from operations
−₹11.6cr 
Free cash flow
−₹11.6cr 
Cash from financing
₹28.5cr 
Cash from investing
−₹13.9cr 
₹ crore except per share
Tap a line for its trendFY23Mar 2023FY22Mar 2022
Adjustments to reconcile profit — non-cash items
5.8—
2.2—
−1.8—
Changes in working capital
−17.1—
−39.1—
25.4—
Cash from operating activities
32.228.4
−2.8—
8.8—
−11.6—
Cash from investing activities
2.8—
−13.921.8
Cash from financing activities
0.03.7
2.52.5
28.52.3
3.01.9
6.33.3
Reference items
21.428.1
9.8%13.3%
−11.6—
−₹20.02—
−0.48×—
8.8—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BPLPHARMA₹1,912.90

Bharat Parenterals Limited

· Pharma & Health
₹ CrorePeersJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOCMcap ₹1,105 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation—5.8
+ Finance Costs—2.2
+ Interest Income—-1.8
Changes in Working Capital
+ Inventories—-17.1
+ Trade Receivables — Current—-39.1
+ Trade Payables — Current—25.4
Cash from Operating Activities
Profit Before Tax (per I/S)28.432.2
Cash from Operations (pre-tax)—-2.8
+ Income Taxes Paid—8.8
Cash from Operating Activities—-11.6
Cash from Investing Activities
+ Interest Received — Investing—2.8
Cash from Investing Activities21.8-13.9
Cash from Financing Activities
+ Proceeds from Borrowings3.70.0
+ Repayment of Borrowings2.52.5
Cash from Financing Activities2.328.5
Net Changes in Cash1.93.0
Closing Cash3.36.3
Reference Items
EBITDA28.121.4
EBITDA Margin %13.289.80
Free Cash Flow (CFO − Capex)—-11.6
Free Cash Flow per Basic Share—-20.02
Cash Flow to Net Income—-0.48
Cash Paid for Taxes—8.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.